Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Norway

PMID:35361849  

 40% with up to ~ 43 kb transgenes. Coupled with a nanopore-based Cas9-targeted sequencing (nCATS), complete verification of precise insertion sequence was achieved. As a proof-of-concept we describe the development of C57BL/6J and NSG Krt18-ACE2 models for SARS-CoV2 research with verified heterozygous N1 animals within ~ 4 months. Additionally, we created a series of mice with diverse backgrounds carrying a single att site including FVB/NJ, PWK/PhJ, NOD/ShiLtJ, CAST/EiJ and DBA/2J allowing for rapid transgene insertion. Combined, this system enables predictable, rapid development with simplified characterization of precisely targeted transgenic animals across multiple genetic backgrounds." />

Efficient targeted transgenesis of large donor DNA into multiple mouse genetic backgrounds using bacteriophage Bxb1 integrase.

Benjamin E Low | Vishnu Hosur | Simon Lesbirel | Michael V Wiles
Scientific reports | 2022

The development of mouse models of human disease and synthetic biology research by targeted transgenesis of large DNA constructs represent a significant genetic engineering hurdle. We developed an efficient, precise, single-copy integration of large transgenes directly into zygotes using multiple mouse genetic backgrounds. We used in vivo Bxb1 mediated recombinase-mediated cassette exchange (RMCE) with a transgene "landing pad" composed of dual heterologous Bxb1 attachment (att) sites in cis, within the Gt(ROSA)26Sor safe harbor locus. RMCE of donor was achieved by microinjection of vector DNA carrying cognate attachment sites flanking the donor transgene with Bxb1-integrase mRNA. This approach achieves perfect vector-free integration of donor constructs at efficiencies > 40% with up to ~ 43 kb transgenes. Coupled with a nanopore-based Cas9-targeted sequencing (nCATS), complete verification of precise insertion sequence was achieved. As a proof-of-concept we describe the development of C57BL/6J and NSG Krt18-ACE2 models for SARS-CoV2 research with verified heterozygous N1 animals within ~ 4 months. Additionally, we created a series of mice with diverse backgrounds carrying a single att site including FVB/NJ, PWK/PhJ, NOD/ShiLtJ, CAST/EiJ and DBA/2J allowing for rapid transgene insertion. Combined, this system enables predictable, rapid development with simplified characterization of precisely targeted transgenic animals across multiple genetic backgrounds.

Pubmed ID: 35361849

Antibodies used in this publication

None found

Associated grants

  • Agency: NIH HHS, United States
    Id: R24 OD021325
  • Agency: NIH HHS, United States
    Id: R21 OD027052
  • Agency: NCI NIH HHS, United States
    Id: P30 CA034196
  • Agency: NIH HHS, United States
    Id: R24 OD 021325
  • Agency: NIH HHS, United States
    Id: U42 OD026635
  • Agency: NIH HHS, United States
    Id: P30CA034196

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


NOD/ShiLtJ (tool)

RRID:IMSR_JAX:001976

Mus musculus with name NOD/ShiLtJ from IMSR.

View all literature mentions

B6.Cg-Tg(K18-ACE2)2Prlmn/J (tool)

RRID:IMSR_JAX:034860

Mus musculus with name B6.Cg-Tg(K18-ACE2)2Prlmn/J from IMSR.

View all literature mentions

B6(Cg)-Tyrc-2J/J (tool)

RRID:IMSR_JAX:000058

Mus musculus with name B6(Cg)-Tyrc-2J/J from IMSR.

View all literature mentions